
Rabeprazole (20mg)
Active composition
Rabeprazole irreversibly inhibits the H+/K+ ATPase enzyme in gastric parietal cells, reducing gastric acid secretion.
Medical applications
Minirab 20 Tablet is a delayed-release tablet containing 20mg of Rabeprazole, a proton pump inhibitor (PPI) used in the treatment of gastroesophageal reflux disease (GERD), erosive esophagitis, and duodenal ulcers. It is also indicated for the treatment of heartburn and other symptoms associated with gastroesophageal reflux. Minirab 20 Tablet works by inhibiting the enzyme system responsible for secreting stomach acid, thereby reducing the production of gastric acid and relieving symptoms. The tablet is designed to release the active ingredient slowly over a period of time, allowing for consistent and prolonged suppression of gastric acid secretion. In clinical trials, Minirab 20 Tablet was shown to be effective in reducing symptoms of GERD, erosive esophagitis, and duodenal ulcers, and was well-tolerated with few side effects. It is recommended for adults and children 12 years and older, and should be taken as directed by a healthcare professional.
Sulfinylbenzimidazole Derivative
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Minirab 20 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Minirab 20 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Minirab 20 Tablet is safe to use in patients with kidney disease. No dose adjustment of Minirab 20 Tablet is recommended.
Exercise Caution
Minirab 20 Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Minirab 20 Tablet is safe to use in patients with liver disease. No dose adjustment of Minirab 20 Tablet is recommended.
Regular Checkup
0 reviews for Minirab 20 Tablet

Rabeprazole (20mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
Rabeprazole irreversibly inhibits the H+/K+ ATPase enzyme in gastric parietal cells, reducing gastric acid secretion.
Medical applications
Minirab 20 Tablet is a delayed-release tablet containing 20mg of Rabeprazole, a proton pump inhibitor (PPI) used in the treatment of gastroesophageal reflux disease (GERD), erosive esophagitis, and duodenal ulcers. It is also indicated for the treatment of heartburn and other symptoms associated with gastroesophageal reflux. Minirab 20 Tablet works by inhibiting the enzyme system responsible for secreting stomach acid, thereby reducing the production of gastric acid and relieving symptoms. The tablet is designed to release the active ingredient slowly over a period of time, allowing for consistent and prolonged suppression of gastric acid secretion. In clinical trials, Minirab 20 Tablet was shown to be effective in reducing symptoms of GERD, erosive esophagitis, and duodenal ulcers, and was well-tolerated with few side effects. It is recommended for adults and children 12 years and older, and should be taken as directed by a healthcare professional.
Sulfinylbenzimidazole Derivative
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Minirab 20 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Minirab 20 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Minirab 20 Tablet is safe to use in patients with kidney disease. No dose adjustment of Minirab 20 Tablet is recommended.
Exercise Caution
Minirab 20 Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Minirab 20 Tablet is safe to use in patients with liver disease. No dose adjustment of Minirab 20 Tablet is recommended.
Regular Checkup
0 reviews for Minirab 20 Tablet















